C. Anthony Hunt
C. Anthony Hunt
Professor of Bioengineering and Therapeutic Sciences
Verified email at ucsf.edu
Cited by
Cited by
Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes
F Olson, CA Hunt, FC Szoka, WJ Vail, D Papahadjopoulos
Biochimica et Biophysica Acta (BBA)-Biomembranes 557 (1), 9-23, 1979
In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom
SB Noonberg, CA Hunt
US Patent 5,624,803, 1997
Liposome disposition in vivo: III. Dose and vesicle-size effects
RM Abra, CA Hunt
Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism 666 (3), 493-503, 1981
Physicochemical properties, solubility, and protein binding of Δ9 ‐tetrahydrocannabinol
ER Garrett, CA Hunt
Journal of pharmaceutical sciences 63 (7), 1056-1064, 1974
Tolerance and disposition of tetrahydrocannabinol in man
CA Hunt, RT Jones
J Pharmacol Exp Ther 215 (1), 35-44, 1980
Synthesis and evaluation of a prototypal artificial red cell
CA Hunt, RR Burnette, RD MacGregor, AE Strubbe, DT Lau, N Taylor, ...
Science 230 (4730), 1165-1168, 1985
Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration
K Hirano, CA Hunt
Journal of pharmaceutical sciences 74 (9), 915-921, 1985
Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme
M Nikanjam, AR Gibbs, CA Hunt, TF Budinger, TM Forte
Journal of controlled release 124 (3), 163-171, 2007
Glucose transport to the brain: a systems model
AA Qutub, CA Hunt
Brain research reviews 49 (3), 595-617, 2005
Method for producing liposomes in selected size range
CA Hunt, DP Papahadjopoulous
US Patent 4,529,561, 1985
Engineering targeted in vivo drug delivery. I. The physiological and physicochemical principles governing opportunities and limitations
CA Hunt, RD MacGregor, RA Siegel
Pharmaceutical research 3 (6), 333-344, 1986
α-Tocopherol retards autoxidation and prolongs the shelf-life of liposomes
CA Hunt, S Tsang
International Journal of Pharmaceutics 8 (2), 101-110, 1981
The metabolic disposition of radiolabeled enkephalins in vitro and in situ
FB Craves, PY Law, CA Hunt, HH Loh
Journal of Pharmacology and Experimental Therapeutics 206 (2), 492-506, 1978
Liposome disposition in vivo: effects of pre-dosing with lipsomes.
RM Abra, ME Bosworth, CA Hunt
Research communications in chemical pathology and pharmacology 29 (2), 349-360, 1980
Pharmacokinetics of Δ9-tetrahydrocannabinol in dogs
ER Garrett, CA Hunt
Journal of pharmaceutical sciences 66 (3), 395-407, 1977
At the biological modeling and simulation frontier
CA Hunt, GEP Ropella, TN Lam, J Tang, SHJ Kim, JA Engelberg, ...
Pharmaceutical research 26 (11), 2369-2400, 2009
Formation of cysts by alveolar type II cells in three-dimensional culture reveals a novel mechanism for epithelial morphogenesis
W Yu, X Fang, A Ewald, K Wong, CA Hunt, Z Werb, MA Matthay, K Mostov
Molecular biology of the cell 18 (5), 1693-1700, 2007
Retention of cytosine arabinoside in mouse lung following intravenous administration in liposomes of different size.
CA Hunt, YM Rustum, E Mayhew, D Papahadjopoulos
Drug Metabolism and Disposition 7 (3), 124-128, 1979
In vivo generation of highly abundant sequence-specific oligonucleotides for antisense and triplex gene regulation
SB Noonberg, GK Scott, MR Garovoy, CC Benz, CA Hunt
Nucleic acids research 22 (14), 2830-2836, 1994
Liposome disposition in vivo VI: delivery to the lung
RM Abra, CA Hunt, DT Lau
Journal of pharmaceutical sciences 73 (2), 203-206, 1984
The system can't perform the operation now. Try again later.
Articles 1–20